Other crucial mutations occurring in phosphatase and tensin homolog (PTEN), and variants of histone 3, the epidermal growth factor receptor (EGFR), Ki-67, and glial fibrillary acidic protein (GFAP) are reported to accelerate the progression of GBM. This evidence concerns the gene GFAP and glioblastoma.